Global In Vitro Diagnostics (IVD) Market Report: 2011 Edition
In-vitro diagnostics (IVD), which includes testing from assays in a controlled environment outside the living organism, accounts for a major share in the global diagnostics market. Despite the global economic crisis, the market registered growth mainly on the back of introduction of novel technologies, rapidly ageing population, increasing health awareness, and increasing contribution of the emerging countries.
On the basis of technology, Immunochemistry dominates the global IVD market, followed by Diabetes Care. North America represents the largest IVD market worldwide, followed by Europe and Japan. In the coming years, these mature markets would offer less potential for growth, whereas the emerging markets like Asia Pacific and Latin America would offer immense potential for growth.
Point of Care (POC), which offers diagnostic services at or near the site of the patient, is more convenient than the traditional tests as it brings the result immediately for fast and better treatment. Some of the other segments which are likely to register significant growth rates in the coming years include Molecular Diagnostics, and Anatomic Pathology. On the back of growth in some of the aforementioned segments, coupled with the increasing healthcare expenditure, rapidly ageing population, increasing diabetic population, as well as the rising per capita income in the emerging countries, the IVD market is expected to benefit in the years to come.
Global IVD industry is consolidated with the top nine players accounting for a major share. In fact, the ongoing mergers and acquisitions in the industry are expected to further increase consolidation. Roche is the market leader, followed by Abbott, Siemens and Johnson & Johnson.
The current report entitled “Global In-vitro Diagnostics (IVD) Market: 2011 Edition”, presents the global market for in-vitro diagnostics as well as its segments. The two leading IVD markets, European Union and North America as well as the two emerging markets for IVD, India and China are being profiled in the report. The report discusses the major drivers promising future growth. Since the IVD industry is highly regulated, the regulatory structure, with a focus on Europe and the US is also being discussed in the report. The major players in the IVD industry have been profiled in this report, highlighting their financials as well as strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
On the basis of technology, Immunochemistry dominates the global IVD market, followed by Diabetes Care. North America represents the largest IVD market worldwide, followed by Europe and Japan. In the coming years, these mature markets would offer less potential for growth, whereas the emerging markets like Asia Pacific and Latin America would offer immense potential for growth.
Point of Care (POC), which offers diagnostic services at or near the site of the patient, is more convenient than the traditional tests as it brings the result immediately for fast and better treatment. Some of the other segments which are likely to register significant growth rates in the coming years include Molecular Diagnostics, and Anatomic Pathology. On the back of growth in some of the aforementioned segments, coupled with the increasing healthcare expenditure, rapidly ageing population, increasing diabetic population, as well as the rising per capita income in the emerging countries, the IVD market is expected to benefit in the years to come.
Global IVD industry is consolidated with the top nine players accounting for a major share. In fact, the ongoing mergers and acquisitions in the industry are expected to further increase consolidation. Roche is the market leader, followed by Abbott, Siemens and Johnson & Johnson.
The current report entitled “Global In-vitro Diagnostics (IVD) Market: 2011 Edition”, presents the global market for in-vitro diagnostics as well as its segments. The two leading IVD markets, European Union and North America as well as the two emerging markets for IVD, India and China are being profiled in the report. The report discusses the major drivers promising future growth. Since the IVD industry is highly regulated, the regulatory structure, with a focus on Europe and the US is also being discussed in the report. The major players in the IVD industry have been profiled in this report, highlighting their financials as well as strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. DIAGNOSTICS MARKET
1.1 Overview
1.2 In Vitro Diagnostic
1.3 IVD Value Chain
2. GLOBAL MARKET ANALYSIS
2.1 Diagnostics Market
Market Value
Market Segments
2.2 IVD Market
Market Value
Major Regional Markets
Market Segmentation
by Application
by Technology
by Disease
by Product Category
by Location
3. PRINCIPAL IVD MARKETS
3.1 European Union IVD Market
Market Value
Breakdown by Country
3.2 North America IVD Market
Overview
Market Value
3.3 China IVD Market
Overview
Market Segments
3.4 India IVD Market
Market Value
Market Segments
4. GROWTH DRIVERS
4.1 Growth in Emerging Markets
4.2 Segmental Growth
4.3 Rising Healthcare Expenditure
4.4 Low Penetration of Vitamin D Tests
4.5 Rapidly Ageing Population
4.6 Significant Patient & Economic Benefits
4.7 Increasing Cost Pressures
4.8 Increasing Diabetes Population
4.9 Reimbursement Conditions
5. REGULATORY STRUCTURE
6. IVD MARKET - COMPETITIVE LANDSCAPE
6.1 Overview
6.2 Consolidation in the IVD Market
7. COMPANY PROFILES
7.1 Roche Holdings AG
Business Description
Key Financials
Business Strategies
Providing Personalized Healthcare
Focus on Unmet Medical Needs
Increase in R&D Initiatives
7.2 Siemens AG
Business Description
Key Financials
Business Strategies
Healthcare Strategy
Focusing on Innovation through R&D
7.3 Abbott Laboratories
Business Description
Key Financials
Business Strategies
Expansion in Emerging Markets
Expanding Product Pipeline
External Growth through Acquisitions
7.4 Beckman Coulter
Business Description
Key Financials
Business Strategies
8. MARKET OUTLOOK
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis
1.1 Overview
1.2 In Vitro Diagnostic
1.3 IVD Value Chain
2. GLOBAL MARKET ANALYSIS
2.1 Diagnostics Market
Market Value
Market Segments
2.2 IVD Market
Market Value
Major Regional Markets
Market Segmentation
by Application
by Technology
by Disease
by Product Category
by Location
3. PRINCIPAL IVD MARKETS
3.1 European Union IVD Market
Market Value
Breakdown by Country
3.2 North America IVD Market
Overview
Market Value
3.3 China IVD Market
Overview
Market Segments
3.4 India IVD Market
Market Value
Market Segments
4. GROWTH DRIVERS
4.1 Growth in Emerging Markets
4.2 Segmental Growth
4.3 Rising Healthcare Expenditure
4.4 Low Penetration of Vitamin D Tests
4.5 Rapidly Ageing Population
4.6 Significant Patient & Economic Benefits
4.7 Increasing Cost Pressures
4.8 Increasing Diabetes Population
4.9 Reimbursement Conditions
5. REGULATORY STRUCTURE
6. IVD MARKET - COMPETITIVE LANDSCAPE
6.1 Overview
6.2 Consolidation in the IVD Market
7. COMPANY PROFILES
7.1 Roche Holdings AG
Business Description
Key Financials
Business Strategies
Providing Personalized Healthcare
Focus on Unmet Medical Needs
Increase in R&D Initiatives
7.2 Siemens AG
Business Description
Key Financials
Business Strategies
Healthcare Strategy
Focusing on Innovation through R&D
7.3 Abbott Laboratories
Business Description
Key Financials
Business Strategies
Expansion in Emerging Markets
Expanding Product Pipeline
External Growth through Acquisitions
7.4 Beckman Coulter
Business Description
Key Financials
Business Strategies
8. MARKET OUTLOOK
8.1 Market Forecast
8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
8.2.3 Regression Analysis
LIST OF CHARTS
IVD Market – Segments by Technology
IVD Market – End Users
IVD Value Chain Analysis in Medical Application
Global Diagnostics Market (2005-2012E)
Global Diagnostics Market – Value Share by Segments (2010)
Global IVD Market (2005-2010)
Top 10 IVD Markets – by Value (2010)
Global IVD Market – Value Share by Application (2010)
Global IVD Market-Segmentation by Technology (2009)
Global IVD Market – Value Share by Type of Disease (2010)
Global IVD Market – Value Share by Product Category (2010)
Point of Care and Clinical Laboratory Testing Share in Global IVD Market (2010E)
Global IVD Market – Value Share by End Sites (2009)
Global IVD Market – Value Share by Region (2010E)
IVD Market in the European Union (2007-2009)
IVD Market in the Europe – by Countries (2009)
North American IVD Market (2010-2013E)
US Diagnostic Testing Market (2010)
China’s IVD Market – Share Breakdown by Value (2010)
Indian IVD Market (2008-2009)
Indian IVD Market – Value Share by Segments (2009)
Indian IVD Market – Growth by Segments (2009 over 2008)
IVD Market Growth – CAGR by Region (2010-2015)
IVD Market Growth – by Segments (2010-2015)
Healthcare Expenditure Worldwide (2005-2012E)
Vitamin D Tests Penetration – by Region (2009)
US Vitamin D Tests Market (2009-2014E)
Europe Vitamin D Tests Market (2009-2014E)
Average Healthcare Spending Worldwide – by Age
Ageing Population Worldwide – age >60 years (2005-2012E)
Diabetic Population Worldwide – age 20-79 years (2005-2012E)
Global IVD Market – Share Breakdown by Region (2010)
Number of M&A Deals in IVD Sector Worldwide (2004-2008)
Roche Holdings Revenue (2006-2010)
Roche Revenue – Share by Segments (2010)
Roche & Genetech-Share of Projects in R&D (Jan 2011)
Roche and Genetech-Share of Projects in Phase III (Jan 11)
Siemens AG Revenue (FY06-FY10)
Siemens Revenue – Share by Segments (FY10)
Abbott Laboratories Revenue (2006-2010)
Abbott Laboratories Revenue – Share by Segments (2010)
Beckman Coulter Revenue (2006-2010)
Beckman Revenue – Share Breakdown by Segments (2010)
Global In Vitro Diagnostics Market (2010-2015E)
IVD Market – Segments by Technology
IVD Market – End Users
IVD Value Chain Analysis in Medical Application
Global Diagnostics Market (2005-2012E)
Global Diagnostics Market – Value Share by Segments (2010)
Global IVD Market (2005-2010)
Top 10 IVD Markets – by Value (2010)
Global IVD Market – Value Share by Application (2010)
Global IVD Market-Segmentation by Technology (2009)
Global IVD Market – Value Share by Type of Disease (2010)
Global IVD Market – Value Share by Product Category (2010)
Point of Care and Clinical Laboratory Testing Share in Global IVD Market (2010E)
Global IVD Market – Value Share by End Sites (2009)
Global IVD Market – Value Share by Region (2010E)
IVD Market in the European Union (2007-2009)
IVD Market in the Europe – by Countries (2009)
North American IVD Market (2010-2013E)
US Diagnostic Testing Market (2010)
China’s IVD Market – Share Breakdown by Value (2010)
Indian IVD Market (2008-2009)
Indian IVD Market – Value Share by Segments (2009)
Indian IVD Market – Growth by Segments (2009 over 2008)
IVD Market Growth – CAGR by Region (2010-2015)
IVD Market Growth – by Segments (2010-2015)
Healthcare Expenditure Worldwide (2005-2012E)
Vitamin D Tests Penetration – by Region (2009)
US Vitamin D Tests Market (2009-2014E)
Europe Vitamin D Tests Market (2009-2014E)
Average Healthcare Spending Worldwide – by Age
Ageing Population Worldwide – age >60 years (2005-2012E)
Diabetic Population Worldwide – age 20-79 years (2005-2012E)
Global IVD Market – Share Breakdown by Region (2010)
Number of M&A Deals in IVD Sector Worldwide (2004-2008)
Roche Holdings Revenue (2006-2010)
Roche Revenue – Share by Segments (2010)
Roche & Genetech-Share of Projects in R&D (Jan 2011)
Roche and Genetech-Share of Projects in Phase III (Jan 11)
Siemens AG Revenue (FY06-FY10)
Siemens Revenue – Share by Segments (FY10)
Abbott Laboratories Revenue (2006-2010)
Abbott Laboratories Revenue – Share by Segments (2010)
Beckman Coulter Revenue (2006-2010)
Beckman Revenue – Share Breakdown by Segments (2010)
Global In Vitro Diagnostics Market (2010-2015E)
LIST OF TABLES
IVD Market Key Players-by Segments
Country-wise Division of European IVD Market (2009)
Top 10 M&A Deals in IVD Sector (2008)
Selected M&A Deals in IVD Sector (early 2009)
Recent M&A Activities in the IVD Market (Oct ’10-Apr ’11)
Dependent & Independent Variables (2005–2010)
Model Summary – Coefficient of Determination
Regression Coefficients Output
IVD Market Key Players-by Segments
Country-wise Division of European IVD Market (2009)
Top 10 M&A Deals in IVD Sector (2008)
Selected M&A Deals in IVD Sector (early 2009)
Recent M&A Activities in the IVD Market (Oct ’10-Apr ’11)
Dependent & Independent Variables (2005–2010)
Model Summary – Coefficient of Determination
Regression Coefficients Output
